Search


	Podcast:		The Journal.
	Episode:		Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?
	Category:		News & Politics
	Duration:		00:19:42
	Publish Date:		2025-05-21 20:00:00
	Description:		Blockbuster drugs. Rising profits. Strong sales. And yet, Novo Nordisk, the Danish company behind the GLP-1 drugs Ozempic and Wegovy, made a surprising move last week: It pushed out its CEO. WSJ's Peter Loftus charts the rise of Ozempic and the fall of CEO Lars Jorgensen. Jessica Mendoza hosts. Further Listening: Trillion Dollar Shot Why WeightWatchers Wants in on Drugs Like Ozempic Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
	Total Play:		0